May 10, 2017 News
HiNT took second place, receiving $5,000 in cash and a $5,000 IP package from iF’s legal partners. They have developed a wearable point-of-care device that can monitor high-risk stroke patients. 20/20 OptimEyes, coming in third, took home $2,500 cash and an IP package valued at $5,000. Their unique, patent-pending drug-delivery system will be used in the form of eye drops for the treatment of dry eye disease. Era Diabetes won the poster prize of $1,500 cash. Other Forge companies who were poster finalists included: Enhanced Medical Nutrition and ImagineMED Inc.
The event showcased 10 teams, who all presented informational posters while the top three presented their innovations live on stage to a judging panel, including executives from GlaxoSmithKline Canada, Stryker Canada, Novatio Ventures and Labtician Ophthalmics Inc.
Congratulations to the 20/20 OptimEyes, Era Diabetes and HiNT teams!